Blockade of human neutrophil activation by 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy]propoxy]phenoxy]benzoic acid (LY293111), a novel leukotriene B4 receptor antagonist

This publication has 32 references indexed in Scilit:

• A novel leukotriene B4-receptor antagonist in endotoxin shock
  Critical Care Medicine, 1993
• Biphenylyl-substituted xanthones: highly potent leukotriene B4 receptor antagonists
  Journal of Medicinal Chemistry, 1993
• Photoaffinity labelling and radiation inactivation of the leukotriene B4 receptor in human myeloid cells
  European Journal of Pharmacology: Molecular Pharmacology, 1993
• Solubilization and characterization of leukotriene B4 receptor-GTP binding protein complex from porcine spleen
  Biochemical and Biophysical Research Communications, 1990
• Analysis of cytosolic ionized calcium variation in polymorphonuclear leukocytes using flow cytometry and Indo-1 AM
  Cytometry, 1989
• Quantitation of lymphocyte intracellular free calcium signals using indo-1
  Cell Calcium, 1988
• Receptor‐specific Mechanisms for the Responses of Human Leukocytes to Leukotrienesa
  Annals of the New York Academy of Sciences, 1988
• Leukotriene involvement in pathologic processes
  Journal of Allergy and Clinical Immunology, 1984
• A practical computer-based approach to the analysis of radioligand binding experiments
  Computer Programs in Biomedicine, 1983
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973